Skip to main content
D

Dialectra

This startup is developing a peritoneal dialysis system that provides personalized electrolyte data. The technology aims to optimize dialysis treatment by offering precise insights into a patient's electrolyte balance.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current peritoneal dialysis methods lack real-time, personalized data on electrolyte balance, hindering the ability to optimize treatment for individual patients. This can lead to suboptimal dialysis outcomes and increased risk of complications.

Solution

This startup is developing a peritoneal dialysis system that integrates real-time electrolyte monitoring to personalize treatment. The system aims to provide continuous data on key electrolytes, allowing for immediate adjustments to dialysis parameters based on the patient's specific needs. By offering precise insights into a patient's electrolyte balance, the technology enables clinicians to optimize dialysis prescriptions, potentially improving patient outcomes and reducing the incidence of complications associated with electrolyte imbalances. The system is designed to be user-friendly and seamlessly integrated into existing dialysis workflows.

Target Audience

The primary target audience includes nephrologists, dialysis nurses, and patients undergoing peritoneal dialysis, as well as hospitals and dialysis centers.

Features

  • Integrated sensor technology for continuous, real-time monitoring of key electrolytes in dialysate.
  • Personalized dialysis prescriptions based on individual patient electrolyte profiles.
  • Wireless data transmission to a secure cloud platform for remote monitoring and analysis.
  • User-friendly interface for clinicians to visualize electrolyte trends and adjust treatment parameters.
  • Automated alerts for critical electrolyte imbalances, enabling timely intervention.
This profile is AI-generated and may contain inaccuracies.